1,720,985 research outputs found

    sj-docx-1-msj-10.1177_13524585221125382 – Supplemental material for Recurrent disability progression endpoints in multiple sclerosis clinical trials

    No full text
    Supplemental material, sj-docx-1-msj-10.1177_13524585221125382 for Recurrent disability progression endpoints in multiple sclerosis clinical trials by Alexandra Bühler, Marcel Wolbers, Fabian Model, Qing Wang, Shibeshih Belachew, Marianna Manfrini, Johannes Lorscheider, Ludwig Kappos and Jan Beyersmann in Multiple Sclerosis Journal</p

    MSJ808189_supplementary_figures – Supplemental material for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial

    No full text
    Supplemental material, MSJ808189_supplementary_figures for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial by Edward J Fox, Clyde Markowitz, Angela Applebee, Xavier Montalban, Jerry S Wolinsky, Shibeshih Belachew, Damian Fiore, Jinglan Pei, Bruno Musch and Gavin Giovannoni in Multiple Sclerosis Journal</p

    sj-pdf-2-msj-10.1177_13524585231162262 – Supplemental material for Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis

    No full text
    Supplemental material, sj-pdf-2-msj-10.1177_13524585231162262 for Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis by Colm Elliott, David A Rudko, Douglas L Arnold, Dumitru Fetco, Ahmed M Elkady, David Araujo, Bing Zhu, Arie Gafson, Zhe Tian, Shibeshih Belachew, Daniel P Bradley and Elizabeth Fisher in Multiple Sclerosis Journal</p

    sj-pdf-4-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

    No full text
    Supplemental material, sj-pdf-4-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p

    MSJ808189_CONSORT_checklist – Supplemental material for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial

    No full text
    Supplemental material, MSJ808189_CONSORT_checklist for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial by Edward J Fox, Clyde Markowitz, Angela Applebee, Xavier Montalban, Jerry S Wolinsky, Shibeshih Belachew, Damian Fiore, Jinglan Pei, Bruno Musch and Gavin Giovannoni in Multiple Sclerosis Journal</p

    sj-pdf-3-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

    No full text
    Supplemental material, sj-pdf-3-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p

    sj-docx-3-msj-10.1177_13524585231162262 – Supplemental material for Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis

    No full text
    Supplemental material, sj-docx-3-msj-10.1177_13524585231162262 for Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis by Colm Elliott, David A Rudko, Douglas L Arnold, Dumitru Fetco, Ahmed M Elkady, David Araujo, Bing Zhu, Arie Gafson, Zhe Tian, Shibeshih Belachew, Daniel P Bradley and Elizabeth Fisher in Multiple Sclerosis Journal</p

    sj-pdf-2-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

    No full text
    Supplemental material, sj-pdf-2-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p

    sj-docx-1-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

    No full text
    Supplemental material, sj-docx-1-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p

    MSJ808189_supplementary_tables – Supplemental material for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial

    No full text
    Supplemental material, MSJ808189_supplementary_tables for Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial by Edward J Fox, Clyde Markowitz, Angela Applebee, Xavier Montalban, Jerry S Wolinsky, Shibeshih Belachew, Damian Fiore, Jinglan Pei, Bruno Musch and Gavin Giovannoni in Multiple Sclerosis Journal</p
    corecore